Latest Content

Dr. Meredith Pelster sat down for an interview with CURE to discuss new data surrounding new treatment outcomes for metastatic pancreatic cancer.

Ampligen and Imfinzi combination therapy demonstrated clinical activity for patients with metastatic pancreatic cancer.

Dietitians share a fiber- and protein-rich pastina bean soup to help patients with colorectal cancer stay nourished and manage GI symptoms during treatment.

Fred Batchelor, a liver cancer survivor, shares lessons on advocacy and why World Cancer Day keeps patients, families and their communities engaged.

After a brain cancer diagnosis, Dr. Bobby Mukkamala says becoming a patient highlighted care barriers, emotions and the need for access and support.

In honor of World Cancer Day, CURE sat down with experts and advocates to discuss the importance of this initiative.

NCCN Guidelines now recommend Trodelvy as a category 1 first-line option for PD-L1–negative metastatic TNBC following phase 3 trial results.

I witnessed that being a patient with cancer requires significant attention and care. Over time, I discovered that how we define our experience — and using a proactive mindset — are meaningful factors in the journey.

Dr. Obeid says genetics and ongoing monitoring guide treatment and survivorship helping patients and families plan ahead and detect recurrence earlier.

World Cancer Day highlights the global impact of cancer, raising awareness, fostering unity and reminding us to support survivors and patients together.

The FDA granted Breakthrough Therapy status to zovegalisib plus Faslodex for patients with PIK3CA-mutated HR+/HER2- advanced breast cancer.

Former U.S. goalkeeper opens up about a large B-cell lymphoma diagnosis and finally reaching remission after CAR T-cell therapy, urging patients to advocate and seek options.

Dr. Joshua Sabari explains how surgery, radiation and therapy may reduce lung capacity and shares steps survivors can take to protect breathing health.